The document summarizes an upcoming two-day conference on operational excellence in clinical trials taking place March 12-13, 2014 in Berlin, Germany. It outlines the conference agenda, topics, and speakers. Over 20 speakers are listed from pharmaceutical and clinical research organizations who will address topics like study feasibility, patient recruitment and retention, social media in recruitment, clinical project management, and conducting global clinical trials. The document provides an overview of the conference objectives, sessions, and opportunities for networking and discussion between professionals in clinical operations and research.
With almost half of oncology studies failing due to a lack of patient retention, there is a critical need to develop more efficient and patient focused strategies. Jessica Thilaganathan at CRF Health sits down with International Clinical Trials to explain why electronic clinical outcome solutions could be the answer. (Published with permission of International Clinical Trials).
The Patient-Centered Clinical Trial: A New ParadigmJohn Reites
Patient centricity is no longer just viewed as an opportunity
solely for commercial pharma. In September 2014,
eyeforpharma brought together 100 US clinical leaders
to discuss the evolving role of patients in clinical trials.
The executive forum addressed the latest trends and
innovations in clinical trial management from a patientcentric
perspective, but it was the presence and involvement
of several patients and patient advocates that shaped the
discussion and expanded our thinking on the topic. Beyond
debating various practical questions, delegates from
pharma began to wonder how the necessary changes might
materialize under the organizational lens.
Lee Wales, VP Strategy Ashfield Healthcare Communications presented at Eyeforpharma 2017 on “The age of personalisation: adopting a customer-focused mindset to create more engaging and effective medical affairs programmes”.
With almost half of oncology studies failing due to a lack of patient retention, there is a critical need to develop more efficient and patient focused strategies. Jessica Thilaganathan at CRF Health sits down with International Clinical Trials to explain why electronic clinical outcome solutions could be the answer. (Published with permission of International Clinical Trials).
The Patient-Centered Clinical Trial: A New ParadigmJohn Reites
Patient centricity is no longer just viewed as an opportunity
solely for commercial pharma. In September 2014,
eyeforpharma brought together 100 US clinical leaders
to discuss the evolving role of patients in clinical trials.
The executive forum addressed the latest trends and
innovations in clinical trial management from a patientcentric
perspective, but it was the presence and involvement
of several patients and patient advocates that shaped the
discussion and expanded our thinking on the topic. Beyond
debating various practical questions, delegates from
pharma began to wonder how the necessary changes might
materialize under the organizational lens.
Lee Wales, VP Strategy Ashfield Healthcare Communications presented at Eyeforpharma 2017 on “The age of personalisation: adopting a customer-focused mindset to create more engaging and effective medical affairs programmes”.
Following our past four highly successful events, this event focuses on “A Critical Guide for Successfully Conducting “6th Annual Clinical Trials Summit 2015” It gives me great pleasure in welcoming all of you to The Virtue Insight’s “6th Annual Clinical Trials Summit 2015”.
1.To discuss:
•strategies to engage physicians in medication reconciliation
•the benefits of medication reconciliation from the perspective of physicians
•physician roles in the medication reconciliation process
2.To provide an opportunity for teams to discuss their MedRec questions and challenges with a panel of physicians
Integrated Health Information to Examine, Empower and EngageH-Connect Compusoft
Electronic Ecosystem to build a universal Electronic Health Record and Health information exchange.
Deliver care through information technology,
Enhance health research, analysis & compliance
Improve efficiency, quality and reduce cost of healthcare. Online health records and Clinical Decision Support System (CDSS) at http://www.hconnect.co.in/
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...CTSI at UCSF
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesCirdan
The appropriate ordering project uses data extracted from Electronic Medical Record to create dashboards to inform and engage clinicians in ordering practices. This presentation looks at the techniques used to create answers for the clinicians questions and discusses the purpose behind 12 dashboards. It looks at the change management approaches and challenges.
The initial pilot project has been embraced by a number of local health districts in NSW and templates have been made available along with training tools.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “7th Annual Clinical Trials Summit 2016” The conference will Be held on 14th May 2016, The Lalit Hotel, Mumbai, India.
Following our past six highly successful events, this event focuses on “A Critical Guide for Successfully Conducting “7th Annual Clinical Trials Summit 2016” It gives me great pleasure in welcoming all of you to The Virtue Insight’s “7th Annual Clinical Trials Summit 2016”. I wish and pray that all our efforts will be beneficial to our industries folks at large.
CONFIRMED SPEAKERS FROM :- Takeda Pharmaceuticals (UK), Clinical Research & Development, Cadila, Sanofi Aventis, Johnson & Johnson, GNH India, Clintech India, Boehringer Ingelheim, Reliance Life Sciences, Abbott, Glenmark Pharmaceuticals, Sanofi, Nishith Desai Associates, Novartis, Tata Consultancy Services, Janssen India (Pharmaceutical companies of Johnson & Johnson), SIRO Clinpharm, and few more..
CONFERENCE BOOKING DETAILS:-
• Standard Price (10th April 2016):- 1 or 2 Delegates - (INR 7,000 + Tax (14.5%) per delegate)
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + Tax (14.5%) per delegate)
• Group Discounts – 5 and above Delegates - (INR 5,500 + Tax (14.5%) per delegate)
• Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to TEL: + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
In case you or any of your colleagues might be interested in participating in the same, please let me know and I will be happy to call you and help you with the registration.
Thank you for your time and consideration. I look forward to hearing from you.
PS: - Please refer your friends or colleagues by forwarding this email to anyone you think may benefit from it.
Best Regards,
Deepak Raj
Delegate and Sponsorship Sales
Virtue Insight
Gsm - + 91 9171350244
Tel - + 91 44 65515693
Skype - edeepakraj143
Using eConsent in Clinical Research to Support Patient Understanding and WelfareCRF Health
Deciding to participate in a clinical trial is not risk-free for any participant. Some studies are designed for healthy volunteers and some are designed for participants with certain medical conditions.
eConsent: Five (5) Key Areas of Preparation CRF Health
Site recruitment and retention of an adequate study population remains a major determinant of the success of a clinical trial. A recent survey to gather opinions on informed consent related to participant understanding, subject recruitment, and retention from 105 respondents' across site-based roles revealed 5 key areas that all sites should consider when preparing an eConsent.
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...SystemOne
In pursuit of the 90–90–90 goals, emphasis has been placed on accelerating centralized laboratory HIV viral load testing of a population that is largely rural and decentralized. Successful
outcome requires effective specimen transport, laboratory testing, and results delivery. This paper focuses on the methods currently employed for results delivery. New innovations in this area are
yielding mixed results; we analyze different approaches and estimate the impact of each on achieving the third ‘90.’
Following our past four highly successful events, this event focuses on “A Critical Guide for Successfully Conducting “6th Annual Clinical Trials Summit 2015” It gives me great pleasure in welcoming all of you to The Virtue Insight’s “6th Annual Clinical Trials Summit 2015”.
1.To discuss:
•strategies to engage physicians in medication reconciliation
•the benefits of medication reconciliation from the perspective of physicians
•physician roles in the medication reconciliation process
2.To provide an opportunity for teams to discuss their MedRec questions and challenges with a panel of physicians
Integrated Health Information to Examine, Empower and EngageH-Connect Compusoft
Electronic Ecosystem to build a universal Electronic Health Record and Health information exchange.
Deliver care through information technology,
Enhance health research, analysis & compliance
Improve efficiency, quality and reduce cost of healthcare. Online health records and Clinical Decision Support System (CDSS) at http://www.hconnect.co.in/
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...CTSI at UCSF
This presentation highlights how the UCSF Clinical and Translational Science Institute (CTSI) enhances and facilitates early-stage research efforts at UCSF and UCSF/industry partnerships - to develop new treatments, diagnostics and prevention.
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesCirdan
The appropriate ordering project uses data extracted from Electronic Medical Record to create dashboards to inform and engage clinicians in ordering practices. This presentation looks at the techniques used to create answers for the clinicians questions and discusses the purpose behind 12 dashboards. It looks at the change management approaches and challenges.
The initial pilot project has been embraced by a number of local health districts in NSW and templates have been made available along with training tools.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “7th Annual Clinical Trials Summit 2016” The conference will Be held on 14th May 2016, The Lalit Hotel, Mumbai, India.
Following our past six highly successful events, this event focuses on “A Critical Guide for Successfully Conducting “7th Annual Clinical Trials Summit 2016” It gives me great pleasure in welcoming all of you to The Virtue Insight’s “7th Annual Clinical Trials Summit 2016”. I wish and pray that all our efforts will be beneficial to our industries folks at large.
CONFIRMED SPEAKERS FROM :- Takeda Pharmaceuticals (UK), Clinical Research & Development, Cadila, Sanofi Aventis, Johnson & Johnson, GNH India, Clintech India, Boehringer Ingelheim, Reliance Life Sciences, Abbott, Glenmark Pharmaceuticals, Sanofi, Nishith Desai Associates, Novartis, Tata Consultancy Services, Janssen India (Pharmaceutical companies of Johnson & Johnson), SIRO Clinpharm, and few more..
CONFERENCE BOOKING DETAILS:-
• Standard Price (10th April 2016):- 1 or 2 Delegates - (INR 7,000 + Tax (14.5%) per delegate)
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + Tax (14.5%) per delegate)
• Group Discounts – 5 and above Delegates - (INR 5,500 + Tax (14.5%) per delegate)
• Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to TEL: + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
In case you or any of your colleagues might be interested in participating in the same, please let me know and I will be happy to call you and help you with the registration.
Thank you for your time and consideration. I look forward to hearing from you.
PS: - Please refer your friends or colleagues by forwarding this email to anyone you think may benefit from it.
Best Regards,
Deepak Raj
Delegate and Sponsorship Sales
Virtue Insight
Gsm - + 91 9171350244
Tel - + 91 44 65515693
Skype - edeepakraj143
Using eConsent in Clinical Research to Support Patient Understanding and WelfareCRF Health
Deciding to participate in a clinical trial is not risk-free for any participant. Some studies are designed for healthy volunteers and some are designed for participants with certain medical conditions.
eConsent: Five (5) Key Areas of Preparation CRF Health
Site recruitment and retention of an adequate study population remains a major determinant of the success of a clinical trial. A recent survey to gather opinions on informed consent related to participant understanding, subject recruitment, and retention from 105 respondents' across site-based roles revealed 5 key areas that all sites should consider when preparing an eConsent.
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...SystemOne
In pursuit of the 90–90–90 goals, emphasis has been placed on accelerating centralized laboratory HIV viral load testing of a population that is largely rural and decentralized. Successful
outcome requires effective specimen transport, laboratory testing, and results delivery. This paper focuses on the methods currently employed for results delivery. New innovations in this area are
yielding mixed results; we analyze different approaches and estimate the impact of each on achieving the third ‘90.’
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...Codemotion
Without empathy, teams with enormous technical skills can fail in their quest to deliver quality products to their users. Fail at empathy, and your chances of failing at everything skyrocket. Empathy is not something you're innately born with - it's a skill that can be learned, cultivated, refined and taught to others. In this Keynote, Leslie Hawthorn will discuss the value of empathy, how you can cultivate it in yourself and your organizational culture, and conclude with concrete steps for leveling up in your interactions with your fellow human beings.
Talk about Micro Feedback and it's virtues, including examples and a case study form us at Brandwatch.
I want to add a big thanks to Sarah Doodey and her work around microfeedback which was inspirational and very helpful for the examples. Check out her UX newsletter too :)
In this presentation for Digital Health Institute Summit 2020 I will explain how we overcame barriers for patient engagement and achieved very high response rates using our ePRO ZEDOC Platform. I'll give real-world insights from a project we ran at the Rheumatology service at NUH in Singapore.
I wear two hats - this talk is with the first one!
A presentation delivered by Derick Mitchell, IPPOSI CEO at the event to celebrate International Clinical Trials Day on May 10th, 2018 in the Mansion House, Dublin, organised by HRB-CRCI.
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...GenesisCareUK
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.”
Innovative Hospital Partnership Model for High Quality Patient Clinical TrialsSGS
The biopharmaceutical industry has a growing need for patient trials, even in early phase, to support an early go-no go decision in compound development. Secured access to the patient population, a professional Clinical Pharmacology Unit environment with trained and experienced medical professionals, expertise in early phase project management and clinical operations are key factors for success.
To meet this industry demand, SGS has invested in SGS operated patient units located in hospital partners both in Belgium and Hungary. These centers are also used to build up further cooperation with neighboring early phase sites. SGS staff are involved in the qualification and tailor-made support of sites to achieve SGS quality and operational requirements.
This presentation will present how this partnership model works and why it is so beneficial for all parties.
For more information visit: https://www.sgs.com/exprimo and contact us at: clinicalresearch@sgs.com
Follow us on LinkedIn: https://www.linkedin.com/company/sgs
National OncoVenture (NOV) is a Korean government funded oncology drug development program. We are focusing on non-clinical and early stage clinical development of promising oncology drug candidates. These candidates are provided by researchers in academics, research institutes, biotech and pharmaceutical companies. We are co-developing the compounds with the originators through a virtual development model. The majority of the development activities are outsourced to domestic and global CRO/CMOs as well as specialized laboratories throughout the world. During the pre-clinical and clinical development, we aim to improve the value of our candidates by out-licensing our development programs to global pharmaceutical companies who can develop them further for the global market.
Patient Engagement is growing in importance as consumer expectations of healthcare providers change and as portals and other technologies improve. Early studies show affects on outcomes for patient engagement technologies
Similar to 2014 Berlin_ Operational Excellence in Clinical Trails (20)
2014 Berlin_ Operational Excellence in Clinical Trails
1. www.kp-morgan.com / info@kp-morgan.com
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conference
Speakers Include:
Jo Burmester,
Director Global Operations,
PharmaSchool Ltd.
Klaus Beinhauer,
Regional Head Global
Monitoring and Site
Management EU
Kai Langel,
Founder and Director,
eClinical Health
Pieter Proot,
Senior Global Trial Leader,
Novartis.
Pete Chan,
Chief Innovation Advocate,
Tudor Reilly Health
Urban Olsson,
Clinical Development Manager,
AstraZeneca
Philippe Auby,
Divisional Director Paediatrics
and CDC, Lundbeck
Dr Ulrike M. Grimm
Vice President, Global Clinical
Operations, Vifor Pharma
Wolfgang Summa,
Vice President of outcomes
delivery and support, ERT
Michaela Kroeger,
Performance & Metrics Lead,
Global Clinical Operations,
Merck Serono.
Aleksandra Jankielewicz,
Clinical Director, Head Europe
North/Central/East Site
Management & Monitoring,
Abbvie
Sanja Bordessoule,
International Clinical Trial
Manager,
Sanofi
Iva Dumbovic Dubravcic,
Clinical Trial Manager,
Roche
Rosamund Round,
Associate Director Patient
Recruitment, Parexel
International
Lydia Dorrego,
Former Clinical Operations
Director, Spain
Yamin Khan, Executive Vice
President Clinical Development,
Pharm-Olam
Jolanta Bilinska, Head of
Department of International
Cooperation National health
Fund Lodz, International
Alliance of Patients
Organizations chair elect
and President Patient Safety
Foundation Poland.
Chairman: Jo Burmester, Director Global Operations, PharmaSchool Ltd & Editor The Journal of
Clinical Research & GCP
Operational Excellence
in Clinical Trials
Summit
Study Feasibility, Patient
Recruitment Retention and Social
Media in Patient Recruitment
12th
– 13th
March 2014,
Berlin, Germany
GOLD SPONSOR
Silver Sponsor
Be the first to place
your logo here
2. OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Operational Excellence
in Clinical Trials Summit
12th – 13th March 2014,
Berlin, Germany
Topics at a Glance: You should not
miss this annual
opportunity
if you are –
Chiefs, Directors,
Heads, Senior
Manager, Leaders
and Executives from
Clinical Operations, Clinical
Developments/Research, Clinical
Trials, Clinical Program, CPM, Study
and Feasibility Management, Global
Monitoring Operations, International
Clinical Research, Patient Recruitment
& Retention, Medical Operations,
Medical Affairs, Medical Advisors, MSL,
Data Management, Compliance and
Regulatory
A basic fact about clinical trial
research:
“Even though a study may be very
well designed and funded,
it cannot bring a drug to market
without the availability of suitable
subject.“
Got a question?
Contact Mr. Andreas Raab
andreas.raab@kp-morgan.com
Tel: +35 31 437 85 75
Web: www.kp-morgan.com
Study Feasibility
• Risk assessment
• Operational risk and competitive risk within
study feasibility and site selection
• Site Selection and Activation
Clinical Project Management –
Communication between sites, CROs &
Patients, Investigators, Clinical Trial Teams
• Importance of effective communication
between sponsor - CROs – sites
• Establishing long run relations between the
site
Risk/Centralised Monitoring
• Effect on quality of the trials
• Impact on patient recruitment
Evaluating the Study budgets
• Minimizing the unpredictable environment on
budget perspective or business perspective
• Minimizing the confusions between sponsors
& physicians/sites/labs
• How to stay ahead with study budgets in
competitive environment
KPIs - Speed, Cheap & Quantity
Patient Recruitment and Retention
• Future of patient recruitment in 2015 and
beyond
• Relationship management in recruitment and
retaining of the patients
• How and why current industry is driven by
patients
• Site staff motivation
• Monitoring plan triggers related to the patient
R&R
• How to maximize study participation
Effectiveness Questionnaire and Data
Management
• Setting up effective questionnaire and
dividing a study feasibility questionnaire
• Privacy and security of personal health
information
Clinical Trial Data Capture – balancing quality,
speed and cost
Clinical Outcome Assessments/ePRO
(electronic Patient-Reported Outcome)
Methods
Successsfully Implementing Global Clinical
Trials using eCOA
Paediatric Clinical Trials: why are they
different?
Outsourcing strategies - Patient recruitment
challenges when studies are outsourced
Implementation of Business Models in Clinical
Trials – Patient Recruitment and Retention
Engagement of Investigators in Business
Models or Clinical Trial protocols
Social Media in Patient Recruitment -
Facebook, blogs, SMS & Advertisement
through Online Communities
• What role can social media play in improving
patient enrolment through clinical sites?
• Patient attitudes and best practices in the
social media recruitment space
• Driving the patients traffics from other
websites, blogs, community sites to Pharma
companies local websites
Digital strategies within the Patient
recruitment and retention
Regulatory/Government Support and
Strategy
Best Models for Site Operations
Latest trend in Clinical Trials and importance
of technology in patient recruitment
• Use of Smartphone apps are increasing in
popularity
• Testing a cheaper way to do clinical research
• How to translate technology/databases
knowledge into identification of patients and
attracting them to clinical trials – current
challenges and opportunities
• Involvement of new technology in forecasting
the result of the clinical trials
Patient Recruitment in Emerging countries
and Challenges for Global Trials
• Challenges for Global Trials and changing
regulatory environments
• Innovative Ideas for Global Patient Recruitment
3. OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Session I 9:15hrs
Risk Based monitoring – Its impact on Patient Recruitment
Jo Burmester, Director Global Operations, PharmaSchool Ltd.
Session II 10:00hrs
Paediatric Clinical Trials: why are they different?
Philippe Auby, Divisional Director Paediatrics and CDC, Lundbeck
• New Regulatery Framework
• Recruitment Challenges
• Case Study: Psychopharmacology Case Studies
10:45hrs Networking Tea & Coffee with Continental
Breakfast
Session III 11:15hrs
How online patient-centric platforms will transform the way
clinical trials are done
Kai Langel, Founder and Director, eClinical Health
Special Feature 12:00hrs
Insight on: Informed consent - it’s role in subject recruitment and
retention Jo Burmester
Interactive Discussion 12:30hrs
• How much information should we really be giving patients?
• Do we make our protocols too restrictive?
• Would you personally take part in a clinical trial?
• What are the ethical issues with recruiting patients in developing
countries?
Panellists: Philippe Auby, Rosamund Round, Pieter Proot, Urban Olsson
13:00hrs Complimentary Lunch
Session IV 14:00hrs
Enrolment and Retention in a Large Diabetes Study
Pieter Proot, Senior Global Trial Leader, Novartis
• Enrolment challenges & how to manage them
• Use of generated data to enhnace enrolment in the study
• Retention Strategies
• Case Study: Type 2 Diabetes Study(Long-Term)
Session V 14:45hrs
Using online tools to accelerate clinical trial recruitment
Pete Chan, Chief Innovation Advocate, Tudor Reilly Health
• Digital trends, the rise of the epatient and a key tipping point in
how patients receive information about clinical trials
• How pharmaceutical-sponsored disease awareness and clinical
trial websites can accelerate patient recruitment; lessons from
recent online recruitment programmes in mental health
• Advantages of independent online health communities versus
pharma-sponsored sites
• How big data can transform the planning and implementation
of clinical trials; highlights from Tudor Reilly Health’s ePatient
InsightsTM analysis in non-small cell lung cancer; how to reach
epatients in a digitally smart way
• Case Study: PracticalAlzheimers.com, Hepatitiscnews.com
15:30hrs Networking Tea & Coffee with Bakery Delights
Session VI 16:00hrs
Global Clinical Studies, Patient Recruitment Challenges and
Observations
Urban Olsson, Clinical Development Manager, AstraZeneca
• Clinical Project Management
• Clinical Outcome Assessments/ ePRO methods
• Patient Recruitment in Emerging Countries and Challenges for
Global Trials
Session VII 16:45hrs – Special Feature
Insight on: How and why current industry is driven by patients
Rosamund Round, Associate Director Patient Recruitment,
Parexel International
• Changing Environment
• Advocacy Group Movement
• Online Communities
Session VIII 17:05hrs
Overcoming Challenges in Emerging Markets
Yamin Mo Khan, Executive Vice President Clinical Development,
Pharm-Olam
• Should we conduct trials in THEK regions?
• Abundance of Patients - A good thing?
• Logistical, Legal and Financial Hurdles
Open Discussion Panel 17:35hrs
Closing Remarks by Jo Burmester, Director Global Operations
PharmaSchool Ltd 18:05 hrs
18:10hrs Cocktail Reception
All attendees are welcome to join at the complimentary cocktail
reception. An extended opportunity to network and benchmark.
DAY 1
8.15 - 9.00
Registration/ check in with tea and coffee
Opening Remarks by Chair – Jo Burmester,
Director Global Operations, PharmaSchool Ltd & Editor
The Journal of Clinical Research & GCP
4. OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Session IX 9:15hrs
Clinical Project Management and Sponsor Oversight
Dr Ulrike M. Grimm, Vice President, Global Clinical Operations,
Vifor Pharma
• KPI’s-benchmarks-dashboards
• Implementation of efficient communication processes
• Risk Management
• Escalation Process
Session X 10:00hrs
Successsfully Implementing Global Clinical Trials using eCOA
Wolfgang Summa, Vice President of outcomes delivery and
support, ERT
• Collecting your eCOA data on a Global Scale
• Picking the right technology solution for your trial based on
Ptaient population, IT infrastructure of participating countries,
validation status of used instruments(Linguistic and Modality)
• Global Support: Translations/Linguistic validation, Submission of
Ethics committees, Logistics / Hardware, Training, Helpdesk
10:45hrs Networking Coffee Break With Continental
Breakfast
Session XI 11:15hrs
KPI’s – Speed, Cheap & Quality
Michaela Kroeger, Performance & Metrics Lead, Global Clinical
Operations, Merck Serono
Session XII 12:00hrs
Improving Clinical Study Site Productivity
Aleksandra Jankielewicz, Clinical Director, Head Europe North/
Central/East Site Management & Monitoring, Abbvie
Interactive Panel Discussion 12:45hrs
• Will Risk Based Monitoring be good or bad for patient
recruitment?
• Is it ethical to use social media to recruit patients?
• How can we get the balance between encouraging recruitment
and coercing patients or encouraging fraud?
• Why do patients withdraw from clinical trials?
Panellists: Ulrike Grimm, Aleksandra Jankeilewicz, Pete Chan
13:15hrs Complimentary Lunch
Session XIII 14:15hrs
Future of Patient Recruitment: Meeting the needs of Patient
Rosamund Round, Associate Director Patient Recruitment,
Parexel International
• Embracing Technology
• Enhancing communication
• Exploring other industries
Session XIV 15:00hrs
Title: Clinical Development Plan
Former Clinical Operations Director, Spain
15:45hrs Networking Coffee Break With Bakery Delights
Session XV 16:15hrs
Patient Empowerment in Clinical Trials
Jolanta Ewa Bilinska, Head of Dept. Int. Cooperation health Fund
Lodz, International Alliance of Patients Organizations
• Mission and Vision of IAPO - how to empower patients
• The proper information for patients about clinical trials
• How to raise awareness about clinical trials
Special Feature 16:45hrs
Open Round Table Discussion to summarize the information
learned through out the 2 days conference to raise final
questions and comments.
Closing Remarks 17:10hrs
Jo Burmester, Director Global Operations PharmaSchool Ltd
17:30hrs Cocktail Reception
All attendees are welcome to join at the complimentary cocktail
reception. An extended opportunity to network and benchmark.
DAY 2
8.15 - 9.00
Registration/ check in with tea and coffee
Opening Remarks by Chair – Jo Burmester
5. OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Patient recruitment and retention offer major challenges to
the clinical researcher with potential for significant impact on
timelines, budgets, and ultimately the scientific integrity of the
trial itself. Many factors affect the recruitment of patients and
difficulty in finding suitable patients is driving the develop-
ment of many innovative methods for accessing new patient
groups. The rise of social media means that new technolo-
gies and changing strategies for communication can be used
to great effect to reach out to patients directly and through
special interest groups, and to communicate with patients
enrolled in clinical trials. How to maximise the benefit of this
approach and ensure our regulatory obligations are appropri-
ately met will be the subject of several sessions during the
summit. Conducting trials in developing countries is becom-
ing more common, because of the potential for large numbers
of treatment naive patients and the willingness of healthcare
staff to learn about clinical research and work with sponsors.
There are, of course, challenges with this approach and dur-
ing the conference there will be opportunities to discuss the
advantages and obstacles, and hear from colleagues working
in these areas. Feasibility studies conducted before a clinical
trial commences can identify risks associated with the trial in
terms of patient recruitment and retention. Also the increasing
emphasis of certain Regulatory Agencies on Risk Assessment
and Risk Based Monitoring can serve to focus our attention on
identifying risks to patient recruitment and therefore develop
strategies to mitigate those risks. There will be sessions during
the summit looking at getting feasibility right, performing risk
assessment in a constructive way and considering the impact
of on-site monitoring on patient recruitment and retention
rates, and how to use this information in a risk based monitor-
ing setting.
A word from the chair
Jo Burmester, Director Global Operations PharmaSchool Ltd and Editor The Journal of
Clinical Research & GCP:
I am very pleased to be involved with this summit on an increasingly important area in
the conduct of clinical trials. The development of new medicines can only continue
if we can recruit patients to our trials and then keep them on board. In my time in the
industry, working with pharmaceutical and biotechnology companies, CROs and non-
commercial researchers, I have seen a dramatic rise in the regulation of clinical trials
and also in public awareness of the advantages and risks of taking part in research as
a patient. These changes offer challenges and opportunities which I look forward to
exploring during the summit.
Conference Benefits:
Opportunity to meet top expert and decision makers from Pharma, Biotech and CRO
industry under one roof.
Venue Berlin
A rewarding opportunity to visit Berlin, Germany
Berlin is a world city of culture, politics, media,
and science. Its economy is primarily based
on high-tech industries and the service sector,
encompassing a diverse range of creative
industries, research facilities, media corporations,
and convention venues. Berlin also serves
as a continental hub for air and rail transport
and is a popular tourist destination. Significant
industries include IT, pharmaceuticals, biomedical
engineering, biotechnology, electronics, traffic
engineering, and renewable energy. Berlin is
home to renowned universities, research institutes,
orchestras, museums, and celebrities and is host
to many sporting events.
Overview
6. Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Registration Form/ Sales Contract
OECT Summit, Berlin, Germany
Organisation Details
Company name:
Address:
Postcode:
Country:
Phone:
VAT Number:
Date: Signat.:
Payment terms: After completion and return of the
registration form, full payment is required within 5 days
from receipt of invoice. Entry may be refuse to dele-
gates who have not paid their invoice in full. A credit
card guarantee may be requested if payment has not
been received in full before the event. There is a 50%
liability on all bookings once made, by fax or email. A
no refund policy exists for cancellation received on or
after one month before the event. Should you decide
to cancel after this date the full invoice must be paid.
However, if you cannot attend the conference, you may
make a substitution (colleague) at least one week be-
fore first day of the event, as long as we are informed
in writing by email or fax. Name changes and substi-
tutions must be from the same company. KPM Events
reserves the right to alter the conference content, tim-
ing, speakers or venue without notice. The event may
be postponed or cancelled due to unforeseen events
beyond the control of KPM events. (Force Majeure:
meaning any circumstances beyond the control of KPM
events, including without limitations to any Act of God,
governmental restrain, fire, tempest, strike or lock-out
(other than by KPM events own employees or agents),
war or act of terrorism. We strongly advise all our con-
ference clients to take out travel insurance. The confer-
ence fee includes refreshments, lunch and conference
material for the event. This fee does not include travel,
hotel accommodation, transfers or insurance, (which
KPM events strongly recommend you obtain). We may
store and process your information for administrative
and purposes and to better understand your needs
and how we can improve our products and services. In
addition, we may use that information to contact you.
Please complete the registration form in full so that we
can contact you with our best services.
Delegate Details #1
Delegate Details #2
Delegate Details #3
Delegate Details #4
JOBTITLE
JOBTITLE
JOBTITLE
JOBTITLE
NAME
NAME
NAME
NAME
TITLE
TITLE
TITLE
TITLE
E-MAIL
E-MAIL
E-MAIL
E-MAIL
Phone
Phone
Phone
Phone
I´m interested, please inform me.
I agree with Terms and conditions
No, thanks. I will manage it on my own.
Kindly mark tick as appropriate:
Accomodation during the conference:
Terms & Conditions:
2190€
2DayC
onference
Please, issue me an invoice to pay by bank transfer.
I would like to pay by credit card.
Get30%
discount on early bird
registration
before 24t
h
Januray2014
Bookings email: operations@kp-morgan.com